In Vivo Stimulation of α- and β-Adrenoceptors in Mice Differentially Alters Small RNA Content of Circulating Extracellular Vesicles

Abstract

When myocardial function is compromised as in heart failure (HF), there is activation of the sympathetic nervous system with elevated circulating catecholamine levels. These catecholamines activate cardiac and extra-cardiac adrenergic receptors (ARs). Interest in secreted extracellular vesicles (EVs) from the heart is growing and in HF, it is not known whether excessive activation of α- or β-adrenergic receptors (ARs) could induce specific changes in EV content. In this study, we have evaluated, by next generation sequencing, the small RNA content, including micro-RNAs (miRs), of circulating EVs of mice exposed to chronic selective α- or β- AR stimulation. EVs from mouse blood were purified by differential ultracentrifugation resulting in EVs with an average size of 116.6 ± 4.8 nm that by immunoblotting included protein markers of EVs. We identified the presence of miRs in blood EVs using miR-21-5p and -16-5p real-time PCR as known constituents of blood exosomes that make up a portion of EVs. We next performed next generation sequencing (NGS) of small non-coding RNAs found in blood EVs from mice following 7 days of chronic treatment with isoproterenol (ISO) or phenylephrine (PE) to stimulate α- or β-ARs, respectively. PE increased the percent of genomic repeat region reads and decreased the percent of miR reads. In miR expression analysis, PE and ISO displayed specific patterns of miR expression that suggests differential pathway regulation. The top 20 KEGG pathways predicted by differential expressed miRs show that PE and ISO share 11 of 20 pathways analyzed and reveal also key differences including three synapse relative pathways induced by ISO relative to PE treatment. Both α-and β-AR agonists can alter small RNA content of circulating blood EVs/exosomes including differential expression and loading of miRs that indicate regulation of distinct pathways. This study provides novel insight into chronic sympathetic nervous system activation in HF where excessive catecholamines may not only participate in pathological remodeling of the heart but alter other organs due to secretion of EVs with altered miR content.

Metoprolol Mitigates Ischemic Heart Remodeling and Fibrosis by Increasing the Expression of AKAP5 in Ischemic Heart

“…Thus, an organ lesion, although not necessarily one in which a structural change occurs, must illustrate that the organ has developed the lesion. Structural alterations are accumulated in response to a variety of humoral and cellular factors as well as various receptors for prolonged periods [ 6 ]. For myocardial remodeling, because the myocardium is nonrenewable, hypertrophy, apoptosis, and remodeling of the glial network outside the cardiomyocyte can be used as entry points to explain myocardial remodeling.…”

Exosome Delivery to the Heart: What Can Brown Fat Do for You?

“…Chronic treatment with the β-AR agonist isoproterenol was recently shown to induce cardiac hypertrophy concomitant with a change in the small RNA content of circulating sEVs in mice, though the tissue source of the small extracellular vesicles (sEVs) was not identified. 16 The highlighted work by Lin et al 12 demonstrates that β 3 -AR activity in brown adipocytes does indeed change the makeup of BAT-derived exosomes at the proteome level, through differential packaging of at least iNOS, but the full extent to which β 3 -AR affects the composition of BAT-derived exosomes remains to be seen. A full-scale proteomic and transcriptomic characterization of β 3 -ARdependent packaging of BAT-derived exosomes would certainly be an interesting and worthwhile endeavor.…”

“…Chronic treatment with the β-AR agonist isoproterenol was recently shown to induce cardiac hypertrophy concomitant with a change in the small RNA content of circulating sEVs in mice, though the tissue source of the small extracellular vesicles (sEVs) was not identified. 16…”